UNC80 (Protein unc-80 homolog) variants and mutations
UNC80 (also known as Protein unc-80 homolog) is a human protein-coding gene encoding a protein unc-80 homolog protein. Within the NALCN complex, it helps control background sodium conductance and neuronal excitability. Biallelic loss-of-function variants cause IHPRF2, with severe hypotonia, developmental impairment, absent or limited speech, and characteristic facial features. This analysis covers 3,484 UNC80 variants and mutations. Of these, 57% have computational variant effect predictions. Disease context includes hypotonia, infantile, with psychomotor retardation and characteristic facies, Intellectual disability, and Encephalopathy. Example UNC80 variants include M1I, V2L, and V2A.
Variant analysis overview
- Gene: UNC80
- Protein: Protein unc-80 homolog
- UniProt accession: Q8N2C7
- Organism: Homo sapiens
- Variants analyzed: 3484
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 3,279 unspecified-consequence records; 105 missense variants; 82 synonymous variants; 7 stop-gained variants; 1 in-frame insertions; 6 frameshift variants; 4 splice-region variants
- Prediction scores: 1,984 variants have prediction scores (57% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: hypotonia, infantile, with psychomotor retardation and characteristic facies, Intellectual disability, Encephalopathy, hypotonia, infantile, with psychomotor retardation and characteristic facies 1, Neurodevelopmental delay, self-injurious ideation, Moderate global developmental delay, Anxiety, hereditary disease, neurodegenerative disease, functional laterality, Global developmental delay.
Protein structure and variant hotspots
- Protein features: 4 transmembrane segments; 3 post-translational modification sites.
- Structural context: 75 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable UNC80 variants
Examples include M1I, V2L, V2A, V2V, K3R, K3K, R4M, R4R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs1320703715, ClinGen CA350124064, ClinVar RCV002880284, MetaLR 0.15, MetaSVM -0.79, Uncertain significance, not provided
- V2L (p.Val2Leu), gnomAD rs1276122734, MetaLR 0.15, MetaSVM -0.87
- V2A (p.Val2Ala), gnomAD 2-209772077-T-C, MetaLR 0.12, MetaSVM -1.03
- V2V (p.Val2Val), rs2076603742, gnomAD 2-209772078-G-C, CADD 10.20
- K3R (p.Lys3Arg), TOPMed rs2076603919
- K3K (p.Lys3Lys), gnomAD 2-209772081-G-A, CADD 9.27
- R4M (p.Arg4Met), gnomAD 2-209772083-G-T, MetaLR 0.08, MetaSVM -1.05
- R4R (p.Arg4Arg), gnomAD 2-209772084-G-A, CADD 13.00
- R4S (p.Arg4Ser), gnomAD 2-209772084-G-T, MetaLR 0.09, MetaSVM -0.98
- K5E (p.Lys5Glu), gnomAD 2-209772085-A-G, MetaLR 0.19, MetaSVM -0.77
- K5N (p.Lys5Asn), gnomAD 2-209772087-G-C, MetaLR 0.16, MetaSVM -0.88
- S6N (p.Ser6Asn), TOPMed rs1229732102, MetaLR 0.14, MetaSVM -0.88
- S6R (p.Ser6Arg), Ensembl rs1574376995, MetaLR 0.14, MetaSVM -0.91
- S6C (p.Ser6Cys), gnomAD 2-209772088-A-T, MetaLR 0.15, MetaSVM -0.85
- S6G (p.Ser6Gly), gnomAD 2-209772088-A-G, MetaLR 0.12, MetaSVM -0.95
- S7F (p.Ser7Phe), ExAC rs749772824, TOPMed rs749772824, gnomAD rs749772824, MetaLR 0.05, MetaSVM -1.07
- S7Y (p.Ser7Tyr), gnomAD 2-209772092-C-A, MetaLR 0.07, MetaSVM -1.02
- S7S (p.Ser7Ser), gnomAD 2-209772093-C-T, CADD 11.60
- E8D (p.Glu8Asp), ExAC rs769004783, MetaLR 0.02, MetaSVM -1.06
- E8G (p.Glu8Gly), NCI-TCGA Cosmic COSV9978, cosmic curated COSV99781, MetaLR 0.04, MetaSVM -1.07, Variant assessed as somatic; moderate impact.
- E8Q (p.Glu8Gln), TOPMed rs1197659901, gnomAD rs1197659901, MetaLR 0.05, MetaSVM -1.08, Uncertain significance, Inborn genetic diseases
- E8* (p.Glu8Ter), gnomAD 2-209772094-G-T, CADD 36.00
- E8K (p.Glu8Lys), gnomAD 2-209772094-G-A, MetaLR 0.04, MetaSVM -1.09
- G9A (p.Gly9Ala), rs1256509145, ClinGen CA350124178, ClinVar RCV001907447, TOPMed rs1256509145, MetaLR 0.05, MetaSVM -1.08, Uncertain significance, not provided
- G9V (p.Gly9Val), TOPMed rs1256509145, gnomAD rs1256509145, MetaLR 0.06, MetaSVM -1.06, Uncertain significance
- G9S (p.Gly9Ser), gnomAD 2-209772097-G-A, MetaLR 0.05, MetaSVM -1.08
- G9D (p.Gly9Asp), gnomAD 2-209772098-G-A, MetaLR 0.03, MetaSVM -1.08
- G9G (p.Gly9Gly), rs1322023930, gnomAD 2-209772099-C-T, CADD 13.50
- Q10* (p.Gln10Ter), gnomAD rs1459352312, CADD 36.00
- Q10L (p.Gln10Leu), TOPMed rs1196785320, gnomAD rs1196785320
- Q10P (p.Gln10Pro), TOPMed rs1196785320, gnomAD rs1196785320, MetaLR 0.04, MetaSVM -1.08
- Q10R (p.Gln10Arg), TOPMed rs1196785320, gnomAD rs1196785320, MetaLR 0.04, MetaSVM -1.07
- Q10K (p.Gln10Lys), gnomAD 2-209772100-C-A, MetaLR 0.04, MetaSVM -1.09
- Q10E (p.Gln10Glu), gnomAD 2-209772100-C-G, MetaLR 0.04, MetaSVM -1.08
- Q10H (p.Gln10His), gnomAD 2-209772102-G-C, MetaLR 0.03, MetaSVM -1.08
- E11* (p.Glu11Ter), NCI-TCGA Cosmic COSV9978, cosmic curated COSV99781, Variant assessed as somatic; high impact.
- E11K (p.Glu11Lys), gnomAD rs1267256792, MetaLR 0.07, MetaSVM -1.08
- Q12E (p.Gln12Glu), gnomAD rs1431960407, MetaLR 0.06, MetaSVM -1.10
- Q12* (p.Gln12Ter), gnomAD 2-209772106-C-T, CADD 36.00
- Q12H (p.Gln12His), gnomAD 2-209772108-G-T, MetaLR 0.05, MetaSVM -1.11
- D13E (p.Asp13Glu), gnomAD rs2076606129, MetaLR 0.02, MetaSVM -1.05
- D13G (p.Asp13Gly), Ensembl rs1432231051, MetaLR 0.05, MetaSVM -1.07
- D13N (p.Asp13Asn), rs2076605926, ClinGen CA350124226, ClinVar RCV001867284, gnomAD rs2076605926, MetaLR 0.05, MetaSVM -1.08, Uncertain significance, not provided
- D13D (p.Asp13Asp), gnomAD 2-209772111-C-T, CADD 11.20
- G14S (p.Gly14Ser), NCI-TCGA Cosmic COSV9977, cosmic curated COSV99778, MetaLR 0.02, MetaSVM -0.97, Variant assessed as somatic; moderate impact.
- G14C (p.Gly14Cys), gnomAD 2-209772112-G-T, MetaLR 0.03, MetaSVM -1.07
- G14D (p.Gly14Asp), gnomAD 2-209772113-G-A, MetaLR 0.03, MetaSVM -1.07
- G14V (p.Gly14Val), gnomAD 2-209772113-G-T, MetaLR 0.04, MetaSVM -1.07
- G14G (p.Gly14Gly), gnomAD 2-209772114-C-T, CADD 13.20
- G15D (p.Gly15Asp), rs1574377240, ClinGen CA350124257, ClinVar RCV001944637, Ensembl rs1574377240, MetaLR 0.04, MetaSVM -1.10, Uncertain significance, not provided
- G15S (p.Gly15Ser), 1000Genomes rs1014521002, TOPMed rs1014521002, gnomAD rs1014521002, MetaLR 0.05, MetaSVM -1.09
- G15C (p.Gly15Cys), gnomAD 2-209772115-G-T, MetaLR 0.04, MetaSVM -1.09
- G15V (p.Gly15Val), gnomAD 2-209772116-G-T, MetaLR 0.05, MetaSVM -1.10
- G15G (p.Gly15Gly), gnomAD 2-209772117-C-T, CADD 12.60
- p.Gly15 Arg16insTer, gnomAD 2-209772117-C-CTA, CADD 28.60
- R16* (p.Arg16Ter), rs2153824303, ClinGen CA2573130384, ClinVar RCV002039883, ClinVar RCV005863503, CADD 30.00, Uncertain significance
- R16H (p.Arg16His), cosmic curated COSV55892, gnomAD rs1477588949, MetaLR 0.06, MetaSVM -1.11, Uncertain significance, Hypotonia, infantile, with psychomotor retardation and characteristic facies 2
- R16S (p.Arg16Ser), gnomAD 2-209772118-C-A, MetaLR 0.05, MetaSVM -1.09
- R16L (p.Arg16Leu), gnomAD 2-209772119-G-T, MetaLR 0.03, MetaSVM -1.06
- R16R (p.Arg16Arg), gnomAD 2-209772120-C-A, CADD 10.50
- G17V (p.Gly17Val), rs2153824309, ClinGen CA350124282, ClinVar RCV002049997, Ensembl rs2153824309, MetaLR 0.15, MetaSVM -0.86, Uncertain significance, not provided
- p.Gly17 Ile18insAspArgAlaGlySerC, gnomAD 2-209772119-G-GAG, CADD 18.60
- G17D (p.Gly17Asp), gnomAD 2-209772122-G-A, MetaLR 0.09, MetaSVM -1.01
- G17G (p.Gly17Gly), gnomAD 2-209772123-C-T, CADD 13.50
- I18V (p.Ile18Val), gnomAD 2-209772124-A-G, MetaLR 0.04, MetaSVM -1.08
- I18T (p.Ile18Thr), gnomAD 2-209772125-T-C, MetaLR 0.11, MetaSVM -0.93
- I18I (p.Ile18Ile), rs1326613587, gnomAD 2-209772126-C-T, CADD 13.10
- P19R (p.Pro19Arg), TOPMed rs1411286673
- P19S (p.Pro19Ser), NCI-TCGA TCGA novel, MetaLR 0.43, MetaSVM -0.13, Variant assessed as somatic; moderate impact.
- P19T (p.Pro19Thr), TOPMed rs2076607238, MetaLR 0.43, MetaSVM -0.13
- P19H (p.Pro19His), gnomAD 2-209772128-C-A, MetaLR 0.45, MetaSVM -0.03
- P19P (p.Pro19Pro), gnomAD 2-209772129-C-A, CADD 9.71
- L20C (p.Leu20Cys), gnomAD 2-209772125-TC-T, CADD 25.20
- L20L (p.Leu20Leu), rs145528914, gnomAD 2-209772130-C-T, CADD 10.80
- L20P (p.Leu20Pro), gnomAD 2-209772131-T-C, MetaLR 0.15, MetaSVM -0.84
- P21A (p.Pro21Ala), TOPMed rs2076607618, gnomAD rs2076607618, MetaLR 0.07, MetaSVM -1.06
- P21S (p.Pro21Ser), cosmic curated COSV10506, TOPMed rs2076607618, gnomAD rs2076607618, MetaLR 0.07, MetaSVM -1.11
- P21T (p.Pro21Thr), gnomAD 2-209772133-C-A, MetaLR 0.08, MetaSVM -1.05
- P21H (p.Pro21His), gnomAD 2-209772134-C-A, MetaLR 0.16, MetaSVM -0.89
- P21P (p.Pro21Pro), gnomAD 2-209772135-C-T, CADD 13.30
- I22I (p.Ile22Ile), gnomAD 2-209772138-C-A, CADD 13.10
- Q23H (p.Gln23His), rs906070422, TOPMed rs906070422, ClinGen CA64662203, ClinVar RCV002577078, MetaLR 0.24, MetaSVM -0.58, Uncertain significance, not provided
- Q23P (p.Gln23Pro), gnomAD 2-209772137-T-TC, CADD 27.50
- Q23* (p.Gln23Ter), gnomAD 2-209772139-C-T, CADD 37.00
- T24A (p.Thr24Ala), rs1402776898, ClinGen CA350124363, ClinVar RCV001988095, TOPMed rs1402776898, MetaLR 0.09, MetaSVM -0.98, Uncertain significance, not provided
- T24I (p.Thr24Ile), TOPMed rs1004014760, gnomAD rs1004014760, MetaLR 0.08, MetaSVM -1.05, Uncertain significance
- T24N (p.Thr24Asn), rs1004014760, ClinGen CA350124366, ClinVar RCV002869724, TOPMed rs1004014760, MetaLR 0.10, MetaSVM -0.99, Uncertain significance, Inborn genetic diseases
- T24S (p.Thr24Ser), gnomAD 2-209772143-C-G, MetaLR 0.08, MetaSVM -1.03
- L26R (p.Leu26Arg), gnomAD 2-209772148-CT-C, CADD 32.00
- L26L (p.Leu26Leu), gnomAD 2-209772148-C-T, CADD 12.50
- W27R (p.Trp27Arg), gnomAD 2-209772151-T-A, MetaLR 0.23, MetaSVM -0.62
- W27* (p.Trp27Ter), gnomAD 2-209772152-G-A, CADD 40.00
- R28W (p.Arg28Trp), NCI-TCGA TCGA novel, MetaLR 0.16, MetaSVM -0.82, Variant assessed as somatic; moderate impact.
- R28R (p.Arg28Arg), rs1282118966, gnomAD 2-209772154-C-A, CADD 14.00
- R28L (p.Arg28Leu), gnomAD 2-209772155-G-T, MetaLR 0.11, MetaSVM -0.85
- T30N (p.Thr30Asn), gnomAD 2-209772161-C-A, MetaLR 0.15, MetaSVM -0.85
- T30T (p.Thr30Thr), rs1298596972, gnomAD 2-209772162-C-T, CADD 21.60
- S31G (p.Ser31Gly), TOPMed rs1015468442, gnomAD rs1015468442, MetaLR 0.17, MetaSVM -0.81
- S31R (p.Ser31Arg), 1000Genomes rs202057181, ExAC rs202057181, TOPMed rs202057181, gnomAD rs202057181, MetaLR 0.16, MetaSVM -0.90
- A32T (p.Ala32Thr), gnomAD rs2076675362, MetaLR 0.16, MetaSVM -0.84
- L34F (p.Leu34Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- L34W (p.Leu34Trp), NCI-TCGA Cosmic COSV5590, cosmic curated COSV55900, Variant assessed as somatic; moderate impact.
- L34L (p.Leu34Leu), gnomAD 2-209773103-G-A, CADD 11.00
- R35S (p.Arg35Ser), gnomAD rs574570420, MetaLR 0.16, MetaSVM -0.87, Likely benign
- R35G (p.Arg35Gly), gnomAD 2-209773104-A-G, MetaLR 0.15, MetaSVM -0.96
- R35R (p.Arg35Arg), rs574570420, gnomAD 2-209773106-G-A, CADD 10.70
- P36A (p.Pro36Ala), rs2153824389, ClinGen CA350124592, ClinVar RCV001983741, Ensembl rs2153824389, AlphaMissense 0.93, MetaLR 0.15, Uncertain significance, not provided
- P36T (p.Pro36Thr), rs2153824389, ClinGen CA350124590, ClinVar RCV003198758, AlphaMissense 0.93, MetaLR 0.15, Uncertain significance, Inborn genetic diseases
- P36L (p.Pro36Leu), gnomAD 2-209773108-C-T, MetaLR 0.21, MetaSVM -0.71
- K37R (p.Lys37Arg), Ensembl rs2076675839, MetaLR 0.24, MetaSVM -0.66
- L38Q (p.Leu38Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G39W (p.Gly39Trp), cosmic curated COSV55909, Ensembl rs2153824390, MetaLR 0.26, MetaSVM -0.58
- G39R (p.Gly39Arg), gnomAD 2-209773116-G-A, MetaLR 0.26, MetaSVM -0.58
- K40N (p.Lys40Asn), TOPMed rs1426304742, gnomAD rs1426304742, MetaLR 0.18, MetaSVM -0.87
- Q41K (p.Gln41Lys), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q41P (p.Gln41Pro), NCI-TCGA TCGA novel, MetaLR 0.17, MetaSVM -0.85, Variant assessed as somatic; moderate impact.
- Q41R (p.Gln41Arg), TOPMed rs1363712852, MetaLR 0.11, MetaSVM -0.97
- Q41Q (p.Gln41Gln), rs1312392285, gnomAD 2-209773124-A-G, CADD 7.87
- Y42H (p.Tyr42His), TOPMed rs1241600548, gnomAD rs1241600548
- Y42Y (p.Tyr42Tyr), rs2076676598, gnomAD 2-209773127-T-C, CADD 8.05
- E43* (p.Glu43Ter), NCI-TCGA Cosmic COSV5589, cosmic curated COSV55892, Variant assessed as somatic; high impact.
- E43D (p.Glu43Asp), gnomAD 2-209773130-A-C, MetaLR 0.17, MetaSVM -0.84
- A44V (p.Ala44Val), rs1430501768, ClinGen CA350124701, ClinVar RCV003036129, TOPMed rs1430501768, MetaLR 0.21, MetaSVM -0.72, Uncertain significance, not provided
- A44T (p.Ala44Thr), gnomAD 2-209773131-G-A, MetaLR 0.21, MetaSVM -0.71
- S45F (p.Ser45Phe), gnomAD 2-209773135-C-T, MetaLR 0.22, MetaSVM -0.69
- C46F (p.Cys46Phe), gnomAD rs1320264327, Uncertain significance
- C46S (p.Cys46Ser), rs1320264327, ClinGen CA350124723, ClinVar RCV002825586, gnomAD rs1320264327, MetaLR 0.24, MetaSVM -0.63, Uncertain significance, not provided
- C46Y (p.Cys46Tyr), NCI-TCGA Cosmic COSV9978, cosmic curated COSV99781, MetaLR 0.31, MetaSVM -0.42, Variant assessed as somatic; moderate impact.
- C46W (p.Cys46Trp), gnomAD 2-209773139-T-G, MetaLR 0.22, MetaSVM -0.80
- V47M (p.Val47Met), TOPMed rs2076677093, MetaLR 0.15, MetaSVM -1.00
- V47V (p.Val47Val), gnomAD 2-209773142-G-T, CADD 25.20
- S48=, NCI-TCGA Cosmic COSV5588, Variant assessed as somatic; low impact.
- S48C (p.Ser48Cys), Ensembl rs2153824559
- S48F (p.Ser48Phe), NCI-TCGA Cosmic COSV9978, cosmic curated COSV99781, Variant assessed as somatic; moderate impact.
- S48S (p.Ser48Ser), gnomAD 2-209775891-C-T, CADD 12.90
- E50Q (p.Glu50Gln), NCI-TCGA Cosmic COSV5588, cosmic curated COSV55883, Variant assessed as somatic; moderate impact.
- R51* (p.Arg51Ter), rs869025320, ClinGen CA351629, cosmic curated COSV55900, ClinVar RCV000207465, CADD 37.00, Pathogenic
- R51L (p.Arg51Leu), TOPMed rs1359174506, gnomAD rs1359174506, MetaLR 0.26, MetaSVM -0.62, Uncertain significance
- R51Q (p.Arg51Gln), rs1359174506, ClinGen CA350130560, ClinVar RCV002001624, TOPMed rs1359174506, MetaLR 0.25, MetaSVM -0.64, Uncertain significance, not provided
- V52M (p.Val52Met), TOPMed rs2076834893, gnomAD rs2076834893, MetaLR 0.34, MetaSVM -0.40
- V52V (p.Val52Val), rs371036835, gnomAD 2-209775903-G-A, CADD 8.51
- L53L (p.Leu53Leu), rs774257370, gnomAD 2-209775906-G-A, CADD 9.78
- E55V (p.Glu55Val), gnomAD 2-209775911-A-T, MetaLR 0.19, MetaSVM -0.79
- E55E (p.Glu55Glu), gnomAD 2-209775912-A-G, CADD 9.13
- N56D (p.Asn56Asp), NCI-TCGA Cosmic COSV5589, cosmic curated COSV55892, MetaLR 0.23, MetaSVM -0.67, Variant assessed as somatic; moderate impact.
- N56K (p.Asn56Lys), TOPMed rs2076835283
- L58P (p.Leu58Pro), rs2153824564, ClinGen CA350130608, ClinVar RCV002024144, Ensembl rs2153824564, AlphaMissense 0.99, MetaLR 0.20, Uncertain significance, not provided
- L58L (p.Leu58Leu), rs1209558371, gnomAD 2-209775919-C-T, CADD 10.10
- H59Q (p.His59Gln), NCI-TCGA Cosmic COSV9977, cosmic curated COSV99778, MetaLR 0.06, MetaSVM -1.11, Variant assessed as somatic; moderate impact.
- H59R (p.His59Arg), 1000Genomes rs201094113, ExAC rs201094113, gnomAD rs201094113, MetaLR 0.12, MetaSVM -1.00
- H59H (p.His59His), gnomAD 2-209775924-T-C, CADD 3.18
- G60V (p.Gly60Val), NCI-TCGA Cosmic COSV5590, MetaLR 0.31, MetaSVM -0.45, Variant assessed as somatic; moderate impact.
- G60S (p.Gly60Ser), gnomAD 2-209775925-G-A, MetaLR 0.31, MetaSVM -0.46
- G60G (p.Gly60Gly), rs60856233, gnomAD 2-209775927-C-T, CADD 10.10
- L61F (p.Leu61Phe), NCI-TCGA Cosmic COSV5589, NCI-TCGA Cosmic COSV5590, cosmic curated COSV55903, Variant assessed as somatic; moderate impact.
- L61I (p.Leu61Ile), NCI-TCGA Cosmic COSV5589, cosmic curated COSV55890, NCI-TCGA Cosmic COSV5590, MetaLR 0.31, MetaSVM -0.49, Variant assessed as somatic; moderate impact.
- L61L (p.Leu61Leu), gnomAD 2-209775930-C-G, CADD 8.03
- P63S (p.Pro63Ser), 1000Genomes rs530266739, ExAC rs530266739, gnomAD rs530266739, MetaLR 0.24, MetaSVM -0.66
- P63T (p.Pro63Thr), 1000Genomes rs530266739, ExAC rs530266739, gnomAD rs530266739, MetaLR 0.24, MetaSVM -0.66
- P63L (p.Pro63Leu), gnomAD 2-209775935-C-T, MetaLR 0.18, MetaSVM -0.75
- P63P (p.Pro63Pro), rs2076836257, gnomAD 2-209775936-A-G, CADD 5.27
- A64P (p.Ala64Pro), rs2076836398, ClinGen CA350130640, ClinVar RCV003047063, MetaLR 0.08, MetaSVM -1.13, Uncertain significance, not provided
- A64T (p.Ala64Thr), rs2076836398, ClinGen CA350130639, ClinVar RCV001961741, Ensembl rs2076836398, MetaLR 0.08, MetaSVM -1.10, Uncertain significance, not provided
- L65L (p.Leu65Leu), rs1386107484, gnomAD 2-209775942-C-T, CADD 7.95
- S66F (p.Ser66Phe), NCI-TCGA Cosmic COSV5589, NCI-TCGA Cosmic COSV9977, cosmic curated COSV99778, Variant assessed as somatic; moderate impact.
- E67Q (p.Glu67Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E67V (p.Glu67Val), NCI-TCGA TCGA novel, MetaLR 0.11, MetaSVM -1.03, Variant assessed as somatic; moderate impact.
- A68D (p.Ala68Asp), gnomAD 2-209775950-C-A, MetaLR 0.30, MetaSVM -0.49
- A68A (p.Ala68Ala), rs547150096, gnomAD 2-209775951-C-T, CADD 11.40
- I69T (p.Ile69Thr), Ensembl rs2076837076
- I69V (p.Ile69Val), TOPMed rs2076836948, MetaLR 0.12, MetaSVM -0.99
- I69F (p.Ile69Phe), gnomAD 2-209775952-A-T, MetaLR 0.23, MetaSVM -0.64
- I69N (p.Ile69Asn), gnomAD 2-209775953-T-A, MetaLR 0.24, MetaSVM -0.63
- Q70E (p.Gln70Glu), TOPMed rs1176675809, gnomAD rs1176675809, MetaLR 0.10, MetaSVM -1.12
- Q70K (p.Gln70Lys), TOPMed rs1176675809, gnomAD rs1176675809, MetaLR 0.10, MetaSVM -1.13
- I72V (p.Ile72Val), ExAC rs755392412, gnomAD rs755392412, MetaLR 0.08, MetaSVM -1.09
- S73F (p.Ser73Phe), cosmic curated COSV55896, Ensembl rs2153824567
- S73T (p.Ser73Thr), rs1022019762, ClinGen CA64645075, ClinVar RCV001888589, TOPMed rs1022019762, MetaLR 0.12, MetaSVM -1.02, Uncertain significance, not provided
- S73Y (p.Ser73Tyr), NCI-TCGA Cosmic COSV5589, NCI-TCGA Cosmic COSV5590, cosmic curated COSV55902, Ensembl rs2153824567, Variant assessed as somatic; moderate impact.
- S73P (p.Ser73Pro), gnomAD 2-209775964-T-C, MetaLR 0.11, MetaSVM -1.07
Public UNC80 analysis runs
- UNC80 analysis run — UNC80 (3,484 variants) — completed 2026-08-20